CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma

Research output: Contribution to journal › Comment/debate

Access to Document

@article{ad5f6e8082e946a59f4b804fcf486f68,

title = "CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma",

author = "Armin Ghobadi and Bartlett, \{Nancy L.\}",

note = "Funding Information: This work was supported by the China National 973 Fund, No. G1999055901.",

year = "2021",

month = sep,

day = "25",

doi = "10.1016/S0140-6736(21)01070-9",

language = "English",

volume = "398",

pages = "1109--1110",

journal = "The Lancet",

issn = "0140-6736",

number = "10306",

}

TY - JOUR

T1 - CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma

AU - Ghobadi, Armin

AU - Bartlett, Nancy L.

N1 - Funding Information: This work was supported by the China National 973 Fund, No. G1999055901.

PY - 2021/9/25

Y1 - 2021/9/25

UR - https://www.scopus.com/pages/publications/85115397023

U2 - 10.1016/S0140-6736(21)01070-9

DO - 10.1016/S0140-6736(21)01070-9

M3 - Comment/debate

C2 - 34508653

AN - SCOPUS:85115397023

SN - 0140-6736

VL - 398

SP - 1109

EP - 1110

JO - The Lancet

JF - The Lancet

IS - 10306

ER -